Back

Conduction abnormalities following aortic valve intervention in patients with transthyretin cardiac amyloidosis

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Transcatheter aortic interventions Intervention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Dan Haberman

Kaplan Medical Center, Rehovot (Israel)

9 More presentations in this session

Presentation thumbnail
Impact of surgery for mitral regurgitation at the time of aortic valve replacement
Doctor N. Kato (Urayasu, JP)
Abstract
Presentation thumbnail
Peripheral vascular access for transcatheter aortic valve implantation: transcarotid versus femoral access
Professor T. Folliguet (Creteil, FR)
Abstract Slides
Presentation thumbnail
The outcome of TAVI in patients with small annulus and the comparison between intra-annular and supra-annular devices in small anulus: From the analysis of the Japanese nationwide registry
Doctor K. Meguro (Kanagawa, JP)
Abstract
Presentation thumbnail
Outcomes of different approaches for severe aortic stenosis: "The Deferred-TAVI", a multicentre study investigating medical and percutaneous therapy in the era of TAVI
Doctor F. Bruno (Turin, IT)
Abstract Slides
Presentation thumbnail
TAVI is associated with less patient-prosthesis-mismatch than surgical aortic valve repair of severe aortic stenosis: A systematic review and meta-analysis
Professor C. Abi Khalil (Doha, QA)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Transcatheter aortic interventions

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources